Yeon-Jin Kwon, Ph.D.
Affiliations: | 2010 | Cell Biology | University of Alabama, Birmingham, Birmingham, AL, United States |
Area:
Cell BiologyGoogle:
"Yeon-Jin Kwon"Parents
Sign in to add mentor| Andra R. Frost | grad student | 2010 | UAB | |
| (The role of Gli1 in ERalpha-negative breast cancer: Promoting survival, migration, invasion, and metastasis.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kadamb R, Bansal N, Leibovitch BA, et al. (2018) Abstract 31: Targeted dissociation of PF1 from SIN3A chromatin regulator complex inhibits tumor growth and metastasis in triple-negative breast cancer Tumor Biology |
| Kwon YJ, Leibovitch BA, Bansal N, et al. (2017) Targeted interference of SIN3A-TGIF1 function by SID decoy treatment inhibits Wnt signaling and invasion in triple negative breast cancer cells. Oncotarget. 8: 88421-88436 |
| Kwon YJ, Leibovitch BA, Bansal N, et al. (2016) Targeted interference of SIN3A-TGIF1 function by SID decoy treatment inhibits Wnt signaling and invasion in triple negative breast cancer cells. Oncotarget |
| Kwon Y. (2016) Mechanism-based management for mucositis: option for treating side effects without compromising the efficacy of cancer therapy. Oncotargets and Therapy. 9: 2007-16 |
| Kwon Y, Leibovitch BA, Bansal N, et al. (2016) Abstract 4115: Inhibition of triple negative breast cancer cell invasion by the targeted interference of Sin3A function affecting Wnt and TGFβ signaling Cancer Research. 76: 4115-4115 |
| Kwon YJ, Petrie K, Leibovitch BA, et al. (2015) Selective inhibition of SIN3 corepressor with avermectins as a novel therapeutic strategy in triple negative breast cancer. Molecular Cancer Therapeutics |
| Spann AL, Yuan K, Goliwas KF, et al. (2015) The presence of primary cilia in cancer cells does not predict responsiveness to modulation of smoothened activity. International Journal of Oncology. 47: 269-79 |
| Bansal N, Wexler J, Kwon Y, et al. (2015) Abstract 1989: Targeting Sin3-Pf1 complex: Novel site-specific epigenetic therapy for triple negative breast cancer Cancer Research. 75: 1989-1989 |
| Kwon Y, Leibovitch BA, Zeng L, et al. (2014) Abstract 807: Selamectin and ivermectin are small molecule inhibitors that interfere with Sin3A-PAH2 function and exert anti-tumor activity in triple-negative breast cancer Cancer Research. 74: 807-807 |
| Kwon YJ, Hurst DR, Steg AD, et al. (2011) Gli1 enhances migration and invasion via up-regulation of MMP-11 and promotes metastasis in ERα negative breast cancer cell lines. Clinical & Experimental Metastasis. 28: 437-49 |